Clinical Trials
Currently Enrolling
- CUSA-081-HEM-01-READY1 Reteplase for Dysfunctional Central Venous Access Devices
- Sorrento Therapeutics, Inc DRP-COV-201US STI-2099 (COVI-DROPS) Intranasal COVID-19 treatment
- DEFINE Study-Janssen Phase 4 HIV patients switching from an Integrase inhibitor with rapid weight gain
- Acurx Pharmaceuticals, LLC-ACX-362F-201 Oral treatment for Clostridium difficile infection
- PRISM 4-FIN-CDI-301 Oral treatment for Clostridium difficile infection
Recently Closed
- SUMMIT-SMT19969/C004 Oral treatment for Clostridium difficile infection
- ATLAS 2 M-GSK 207966 HIV-1 Intramuscular treatment
- ATLAS 2 M Sub-Study HIV-1 Intramuscular long-acting treatment
- ATLAS 1-GSK 201585 HIV-1 transition from current INI-NNRTI to long-acting treatment
- TANGO GSK 204862 HIV-1 Devoto